Portfolio of Coronavirus Treatment and Vaccine Stocks
The following table includes 19 coronavirus treatment and vaccine stocks. For more information about these stocks see These 19 companies are working on coronavirus treatments or vaccines — here’s where things stand.
|19 Coronavirus Treatment and Vaccine Stocks|
|Johnson & Johnson||JNJ|
|Takeda Pharmaceutical Company Ltd.||TAK|
|Price charts from Alpha Vantage as of most recent close.|
To inspect the performance of the Coronavirus Treatment and Vaccine Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 13 stocks included in the portfolio computations are: AZN, CYDY, EBS, GILD, GSK, INO, JNJ, NVAX, PFE, REGN, RHHBY, SNY and TAK. The current value of the portfolio assumes that $769.23 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 6 stocks excluded from the portfolio computations because of insufficient price data are: BNTX, MESO, MRNA, TBIO, VXRT and VIR.
The current value of a $10,000 investment is $15,091. The percent return is 50.91%. The annualized return is 8.58%.